Arcadia Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,584
Closed -$129K 304
2024
Q4
$129K Buy
+3,584
New +$121K 0.02% 149
2024
Q3
Sell
-1,851
Closed -$74.7K 320
2024
Q2
$74.7K Hold
1,851
0.01% 175
2024
Q1
$65.5K Buy
1,851
+1,085
+142% +$29.1K 0.01% 186
2023
Q4
$22.7K Buy
+766
New +$15.9K ﹤0.01% 250

Other funds holding TNDM

Arcadia Investment Management's TNDM Position: Q1 2025 in Review

Arcadia Investment Management sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 3,584 shares — an estimated $129K sold.

Arcadia Investment Management first reported a position in TNDM in Q4 2023 and held it in 4 quarters. The position peaked at $129K in Q4 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Arcadia Investment Management reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Arcadia Investment Management sold 3,584 Tandem Diabetes Care shares in Q1 2025, an estimated $129K.
  • Arcadia Investment Management first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 4 quarters.
  • Arcadia Investment Management's Tandem Diabetes Care position peaked at $129K in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Arcadia Investment Management's 13F filing for Q1 2025, filed 30 Apr 2025.